| Literature DB >> 23538408 |
G Suffredini1, J E East2, L M Levy3.
Abstract
SUMMARY: Advances in nanotechnology have the potential to dramatically enhance the detection of neurologic diseases with targeted contrast agents and to facilitate the delivery of focused therapies to the central nervous system. We present the physicochemical rationale for their use, applications in animal models, and ongoing clinical trials using these approaches. We highlight advances in the use of nanoparticles applied to brain tumor imaging, tumor angiogenesis, neurodegeneration, grafted stem cells, and neuroprogenitor cells.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23538408 PMCID: PMC7966599 DOI: 10.3174/ajnr.A3543
Source DB: PubMed Journal: AJNR Am J Neuroradiol ISSN: 0195-6108 Impact factor: 3.825